Puma Biotechnology
PBYI
PBYI
127 hedge funds and large institutions have $355M invested in Puma Biotechnology in 2020 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 36 increasing their positions, 44 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
18% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 44
35% less call options, than puts
Call options by funds: $2.16M | Put options by funds: $3.33M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
127
Holding in Top 10
–
Calls
$2.16M
Puts
$3.33M
Top Buyers
| 1 | +$28.5M | |
| 2 | +$10.2M | |
| 3 | +$8.66M | |
| 4 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$6.86M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$3.2M |
Top Sellers
| 1 | -$9.44M | |
| 2 | -$8.6M | |
| 3 | -$7.28M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$5.58M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$3.99M |